AI in Biopharma Manufacturing: Are We There Yet? podcast

Five Trends: How the Expectations Are Evolving

0:00
36:31
Rewind 15 seconds
Fast Forward 15 seconds
Before reading any single document, you need the map. Sam and Sarah sort the AI-in-manufacturing rulebook into its four layers, replace "binding or not" with maturity and who-will-ask, and trace five trends across the documents: from models to AI, from model-agnostic to Annex 22's line on model type, from validation to lifecycle, from regional to the joint EMA-FDA principles and ICH's reflection paper, and from silence on generative AI to a gap everyone can see. The recurring cast is introduced, and the agentic assistant that drafts deviation investigations is walked down the maturity axis to show how little the documents yet say about it, and how a site reasons about it anyway. Researched, scripted and voiced by AI systems under Jack Prior's direction. Sam and Sarah are AI characters; nothing in the episode is Jack speaking, and none of it is a statement of his views or his employer's. Generative AI can be confidently wrong — check the sources. Corrections: [email protected]. Transcript: https://jackprior.ai/podcast/transcript/01-five-moves.html Documents discussed: AI CMC Regulatory Landscape: https://jackprior.ai/ai-cmc-landscape/ EMA + FDA — Guiding Principles of Good AI Practice in Drug Development: https://www.ema.europa.eu/en/documents/other/guiding-principles-good-ai-practice-drug-development_en.pdf Reflection Paper on proposed ICH work to facilitate Advanced Pharmaceutical Manufacturing: https://admin.ich.org/sites/default/files/2026-03/ICH_ReflectionPaper_AdvancedManufacturing_2025_1008_0.pdf Considerations for the Use of AI to Support Regulatory Decision-Making for Drug and Biological Products: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-artificial-intelligence-support-regulatory-decision-making-drug-and-biological Fact check: 148 factual claims in this episode were checked against the source documents by an independent AI pass: 121 are supported by the primary text, 20 are confirmed by official web sources, 6 rest on secondary sources or are hedged as such (listed in the report), 1 corrected before release, 0 open. Full report: https://jackprior.ai/podcast/factcheck/01-five-moves.html

More episodes from "AI in Biopharma Manufacturing: Are We There Yet?"